Table 5.
Medication profiles of the three patient groups.
| Class of medication | Depression (n = 32) | Maniaa (n = 22) | Euthymia (n = 25) | All (n = 79) |
|---|---|---|---|---|
| MOOD STABILIZERS (MS) | ||||
| Lithium | 11 | 12 | 12 | 35 |
| Sodium valproate | 6 | 11 | 5 | 22 |
| Lamotrigine | 18 | 7 | 7 | 32 |
| Topiramate | 1 | 0 | 0 | 1 |
| Gabapentin | 0 | 1 | 0 | 1 |
| Total (MS) | 36 | 31 | 24 | 91 |
| ANTIPSYCHOTICS (AP) | ||||
| Olanzapine | 3 | 3 | 2 | 8 |
| Quetiapine | 8 | 6 | 5 | 19 |
| Aripiprazole | 10 | 6 | 8 | 24 |
| Other | 4 | 6 | 2 | 12 |
| Total (AP) | 25 | 21 | 17 | 63 |
| ANTIDEPRESSANTS (AD) | ||||
| SSRI | 8 | 3 | 1 | 12 |
| SNRI | 5 | 0 | 2 | 7 |
| NaSSA | 1 | 0 | 1 | 2 |
| Trazodone | 1 | 0 | 1 | 2 |
| Other | 1 | 0 | 0 | 1 |
| Total (AD) | 16 | 3 | 5 | 24 |
| Benzodiazepine (BZ) | 27 | 24 | 15 | 66 |
| MEDICATION COMBINATION | ||||
| MS | 6 | 4 | 5 | 15 |
| AP | 2 | 1 | 2 | 5 |
| AD | 0 | 0 | 0 | 0 |
| MS + AP | 11 | 13 | 12 | 36 |
| MS + AD | 3 | 1 | 2 | 6 |
| AP + AD | 3 | 1 | 1 | 5 |
| MS + AP + AD | 7 | 2 | 2 | 11 |
| Drug-free | 0 | 0 | 1 | 1 |
MS, Mood stabilizers; AP, Antipsychotics; AD, Antidepressants; SSRI, Selective Serotonin Reuptake Inhibitor; SNRI, Serotonin and Noradrenaline Reuptake Inhibitor; NaSSA, Noradrenergic and Specific Serotonergic Antidepressant; BZ, Benzodiazepine.
a
Including mania and hypomania patients.